SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205 | -1.0% | 8,861 | +12.4% | 0.00% | 0.0% |
| Q2 2023 | $207 | +99.0% | 7,884 | +94.2% | 0.00% | +100.0% |
| Q1 2023 | $104 | -16.8% | 4,059 | -15.4% | 0.00% | 0.0% |
| Q4 2022 | $125 | -99.9% | 4,799 | +3.7% | 0.00% | 0.0% |
| Q3 2022 | $132,000 | +16.8% | 4,626 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $113,000 | -58.0% | 4,610 | -3.2% | 0.00% | -50.0% |
| Q1 2022 | $269,000 | -57.8% | 4,761 | -53.7% | 0.00% | 0.0% |
| Q4 2021 | $638,000 | +92.7% | 10,278 | +97.1% | 0.00% | -33.3% |
| Q3 2021 | $331,000 | -27.1% | 5,214 | -5.4% | 0.00% | -25.0% |
| Q2 2021 | $454,000 | +81.6% | 5,513 | +62.5% | 0.00% | -55.6% |
| Q1 2021 | $250,000 | -7.7% | 3,393 | -9.1% | 0.01% | -10.0% |
| Q4 2020 | $271,000 | – | 3,733 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |